Abiomed Inc. (ABMD): Price and Financial Metrics


Abiomed Inc. (ABMD): $349.68

3.26 (+0.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ABMD POWR Grades


  • ABMD scores best on the Quality dimension, with a Quality rank ahead of 89.76% of US stocks.
  • ABMD's strongest trending metric is Quality; it's been moving down over the last 52 weeks.
  • ABMD's current lowest rank is in the Value metric (where it is better than 18.87% of US stocks).

ABMD Stock Summary

  • ABMD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 7,276.03 -- higher than 99.52% of US-listed equities with positive expected earnings growth.
  • With a price/earnings ratio of 102.69, Abiomed Inc P/E ratio is greater than that of about 92.21% of stocks in our set with positive earnings.
  • The ratio of debt to operating expenses for Abiomed Inc is higher than it is for about merely 0.5% of US stocks.
  • Stocks that are quantitatively similar to ABMD, based on their financial statements, market capitalization, and price volatility, are JAZZ, MASI, ANIK, TTWO, and QGEN.
  • ABMD's SEC filings can be seen here. And to visit Abiomed Inc's official web site, go to www.abiomed.com.

ABMD Valuation Summary

  • In comparison to the median Healthcare stock, ABMD's price/sales ratio is 365.79% higher, now standing at 17.7.
  • Over the past 243 months, ABMD's price/earnings ratio has gone up 128.3.
  • ABMD's price/sales ratio has moved up 4.3 over the prior 243 months.

Below are key valuation metrics over time for ABMD.

Stock Date P/S P/B P/E EV/EBIT
ABMD 2021-08-31 17.7 12.6 107.0 75.0
ABMD 2021-08-30 17.5 12.5 106.1 74.4
ABMD 2021-08-27 17.4 12.4 105.4 73.9
ABMD 2021-08-26 17.4 12.4 105.4 73.9
ABMD 2021-08-25 17.4 12.4 105.2 73.8
ABMD 2021-08-24 17.4 12.4 105.1 73.7

ABMD Growth Metrics

  • Its year over year cash and equivalents growth rate is now at 20.99%.
  • Its year over year price growth rate is now at 42.62%.
  • Its 4 year cash and equivalents growth rate is now at 298.79%.
ABMD's revenue has moved up $94,374,000 over the prior 15 months.

The table below shows ABMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 935.257 298.178 154.412
2021-03-31 847.522 274.578 225.525
2020-12-31 812.935 274.696 200.467
2020-09-30 802.856 285.001 207.816
2020-06-30 798.066 282.051 158.674
2020-03-31 840.883 314.92 203.009

ABMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ABMD has a Quality Grade of B, ranking ahead of 89.72% of graded US stocks.
  • ABMD's asset turnover comes in at 0.655 -- ranking 58th of 185 Medical Equipment stocks.
  • INGN, ATRC, and BSX are the stocks whose asset turnover ratios are most correlated with ABMD.

The table below shows ABMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.655 0.817 0.217
2021-03-31 0.616 0.809 0.303
2020-12-31 0.623 0.809 0.278
2020-09-30 0.643 0.808 0.303
2020-06-30 0.667 0.812 0.248
2020-03-31 0.721 0.820 0.293

ABMD Price Target

For more insight on analysts targets of ABMD, see our ABMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $387.33 Average Broker Recommendation 1.65 (Moderate Buy)

ABMD Stock Price Chart Interactive Chart >

Price chart for ABMD

ABMD Price/Volume Stats

Current price $349.68 52-week high $387.40
Prev. close $346.42 52-week low $242.73
Day low $343.75 Volume 137,800
Day high $350.56 Avg. volume 259,348
50-day MA $346.44 Dividend yield N/A
200-day MA $323.24 Market Cap 15.87B

Abiomed Inc. (ABMD) Company Bio


Abiomed Inc. develops, and sells medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. The company was founded in 1981 and is based in Danvers, Massachusetts.


ABMD Latest News Stream


Event/Time News Detail
Loading, please wait...

ABMD Latest Social Stream


Loading social stream, please wait...

View Full ABMD Social Stream

Latest ABMD News From Around the Web

Below are the latest news stories about Abiomed Inc that investors may wish to consider to help them evaluate ABMD as an investment opportunity.

Abiomed Second Quarter Fiscal 2022 Earnings and Conference Call Notification

DANVERS, Mass., October 07, 2021--Abiomed second quarter fiscal 2022 earnings and conference call notification.

Yahoo | October 7, 2021

Abiomed (ABMD) Stock Jumps 5.9%: Will It Continue to Soar?

Abiomed (ABMD) shares rallied 5.9% in the last trading session to close at $332.47. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock''s 15.8% loss over the past four weeks.

iShook Finance | October 6, 2021

Cardiac Assist Devices Market 2021 Global Analysis by Key Players Terumo Corporation, BERLIN HEART GmbH, MAQUET GmbH, Teleflex Incorporated, ABIOMED Inc, Abbott Laboratories, Medtronic PLC, CARMAT SA

Cardiac Assist Devices or CADs are the heart pumping devices that work along-side heart and are used to stabilize the pumping ability and proper maintenance of the blood flow in the body. Increase in the government funding in the research

OpenPR | September 23, 2021

Here's Why You Should Retain Abiomed (ABMD) Stock For Now

Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.

Yahoo | September 20, 2021

New Study from StrategyR Highlights a $80.1 Million Global Market for Tipper Trucks by 2026

SAN FRANCISCO , Sept. 15, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Tipper Trucks - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace. FACTS AT A GLANCE Edition: 9; Released: April 2021 Executive Pool: 422 Companies: 43 - Players covered include Abbott Vascular; Abiomed, Inc.; AtriCure, Inc.; BEML Ltd.; Biosensors International Group Ltd.; Biotronik SE & Co. KG; BioVentrix, Inc.; Caterpillar, Inc.; Hitachi Construction Machinery Co., Ltd.; Komatsu Ltd.; OJSC Belaz and Others. Coverage: All major geographies and key segments Segments: Segment (Tipper Truc...

Benzinga | September 15, 2021

Read More 'ABMD' Stories Here

ABMD Price Returns

1-mo 1.36%
3-mo 6.44%
6-mo -0.38%
1-year 28.28%
3-year -4.51%
5-year 180.08%
YTD 7.86%
2020 90.05%
2019 -47.52%
2018 73.44%
2017 66.32%
2016 24.81%

Continue Researching ABMD

Here are a few links from around the web to help you further your research on Abiomed Inc's stock as an investment opportunity:

Abiomed Inc (ABMD) Stock Price | Nasdaq
Abiomed Inc (ABMD) Stock Quote, History and News - Yahoo Finance
Abiomed Inc (ABMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8866 seconds.